Form 4: Integra LifeSciences Director Barbara Hill Increases Stake in Company
SEC Form 4 Filing
Director Barbara Hill reports purchasing 36,350 shares of Integra LifeSciences Holdings Corp (IART) at an average price of $27.3952 on May 21, 2024.
Summary
- On May 21, 2024, Barbara B Hill, a director of Integra LifeSciences Holdings Corp, purchased 36,350 shares of the company's common stock.
- The shares were bought at a weighted average price of $27.3952, with individual prices ranging from $27.15 to $27.47.
- Following the transaction, Ms. Hill directly owns 100,322 shares and indirectly owns 36,350 shares through a trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but it's a single transaction and doesn't provide a comprehensive view of the company's financial health.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, buys or sells shares of their company. It provides transparency to the market regarding the transactions of those with privileged information.
Stakeholder Impact
- Shareholders may view the director's stock purchase as a positive sign.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of transaction: Barbara Hill purchased shares of Integra LifeSciences. |
| 05/22/2024 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.